Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years-Reference-Cited by-同舟云学术

Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years

Published:2019-07-08 Issue:14 Volume:60 Page:3536-3543
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Bashir Qaiser¹,Chamoun Kamal¹,Milton Denái R.²,Khan Maliha¹,Ahmed Sairah¹,Mehta Rohtesh¹,Popat Uday R.¹,Kebriaei Partow¹,Nieto Yago¹,Oran Betul¹,Ciurea Stefan O.¹,Hosing Chitra¹,Khouri Isa¹,Patel Krina³,Manasanch Elisabet E.³,Lee Hans C.³,Orlowski Robert Z.³,Champlin Richard E.¹,Qazilbash Muzaffar H.¹

Affiliation:

1. Department of Stem Cell Transplantation and Cellular Therapy, UT MD Anderson Cancer Center, Houston, TX, USA;

2. Department of Biostatistics, UT MD Anderson Cancer Center, Houston, TX, USA;

3. Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA

Funder

National Institutes of Health through MD Anderson's Cancer Center Support

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1633633